| ENGNW Stock | | | 0.94 0.02 2.17% |
Founder
DSc FRSC is CoFounder Board of enGene Holdings Warrants
| Address | 4868 Rue Levy, Montreal, QC, Canada, H4R 2P1 |
| Phone | 514 332 4888 |
| Web | https://www.engene.com |
EnGene Holdings Management Efficiency
The company has return on total asset
(ROA) of
(0.2207) % which means that it has lost $0.2207 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(1.2306) %, meaning that it generated substantial loss on money invested by shareholders. EnGene Holdings' management efficiency ratios could be used to measure how well EnGene Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
Return On Tangible Assets is likely to climb to 0.17 in 2025.
Return On Capital Employed is likely to climb to 0.20 in 2025. At this time, EnGene Holdings'
Total Assets are fairly stable compared to the past year.
Non Current Assets Total is likely to climb to about 77.1
M in 2025, whereas
Debt To Assets are likely to drop 0.01 in 2025.
enGene Holdings Warrants (ENGNW) is traded on NASDAQ Exchange in USA. It is located in 4868 Rue Levy, Montreal, QC, Canada, H4R 2P1 and employs 31 people. EnGene Holdings is listed under Biotechnology category by Fama And French industry classification.
Management Performance
enGene Holdings Warrants Leadership Team
Elected by the shareholders, the EnGene Holdings' board of directors comprises two types of representatives: EnGene Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EnGene. The board's role is to monitor EnGene Holdings' management team and ensure that shareholders' interests are well served. EnGene Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EnGene Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| DSc FRSC, CoFounder Board | |
| Joan Connolly, Chief Officer | |
| Anthony Cheung, CoFounder Officer | |
| Raj MD, Chief Officer | |
| JD Esq, CEO Director | |
| Ronald Cooper, Chief Director | |
| Alex Nichols, President COO | |
| Dr MSc, Chief Officer | |
| David Daws, CFO Development | |
| MBChB MFPM, Chief Officer | |
| Lee Giguere, Chief Secretary | |
| FACS MD, Chief Officer | |
| Sharon Tan, VP Management | |
| Paul Erickson, NonExecutive Director | |
EnGene Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EnGene Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for EnGene Stock Analysis
When running EnGene Holdings' price analysis, check to
measure EnGene Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EnGene Holdings is operating at the current time. Most of EnGene Holdings' value examination focuses on studying past and present price action to
predict the probability of EnGene Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EnGene Holdings' price. Additionally, you may evaluate how the addition of EnGene Holdings to your portfolios can decrease your overall portfolio volatility.